Analyses of Acceptability Judgments Made Toward the Use of Nanocarrier-Based Targeted Drug Delivery: Interviews with Researchers and Research Trainees in the Field of New Technologies
Crossref DOI link: https://doi.org/10.1007/s11569-015-0241-2
Published Online: 2015-10-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chenel, Vanessa
Boissy, Patrick
Cloarec, Jean-Pierre
Patenaude, Johane
Funding for this research was provided by:
Canadian Institutes for Health Research (43854)
License valid from 2015-10-29